(556344), L. N., (9694532), Y. W., (85787), F. Z., (14917341), Y. H., (14917344), L. C., (454357), W. X., . . . (102628), M. H. (2020). Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer.
Chicago Style (17th ed.) Citation(556344), Lei Nie, et al. Author Correction: CDK2-mediated Site-specific Phosphorylation of EZH2 Drives and Maintains Triple-negative Breast Cancer. 2020.
MLA (9th ed.) Citation(556344), Lei Nie, et al. Author Correction: CDK2-mediated Site-specific Phosphorylation of EZH2 Drives and Maintains Triple-negative Breast Cancer. 2020.
Warning: These citations may not always be 100% accurate.